References
- Mitchell G A, Lambert M, Tanguay R M. Hypertyrosinemia. The Metabolic and Molecular Bases of Inherited Disease, 7th ed., C R Scriver, A L Beaudet, W S Sly, D Valle. McGraw-Hill, New York 1995; 1077–1106
- Croffie J M, Gupta S K, Chong S K, Fitzgerald J F. Tyrosinemia type I should be suspected in infants with severe coagulopathy even in the absence of other signs of liver failure. Pediatrics 1999; 103: 675–678
- Holme Lindstedt E. S. Diagnosis and management of tyrosinemia type I. Cur Opin Pediatr 1995; 7: 726–732
- Grompe M. Therapeutic liver repopulation for the treatment of metabolic liver diseases. Hum Cell 1999; 12: 171–180
- Lindstedt S, Holme E, Lock E A, Hjalmarson O, Strandvik B. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992; 340: 813–817